A polysaccharide-containing component, more accurately a glycolipoprotein (GLP), obtained from the extracellular slime layer of Pseudomonas aeruginosa strain BI has been shown to possess several interesting biological characteristics relating to pathogenesis (27) and phage-host cell interaction (6, 11, 24) .
When injected into mice the purified GLP produces leucopenic and lethal effects, mimicking the events observed during lethal infection initiated with viable bacilli (27) . Active or passive immunization protects against these responses. In vitro, the GLP also has been observed to inhibit phagocytosis (27) . A possible role in experimental infection was further supported by the demonstration of its in vivo production, dissemination into the peripheral circulation, and ability to associate with erythrocytes of mice lethally infected with viable bacilli (12) . The extracellular GLP has been shown to be distinct chemically, physically, and immunologically from lipopolysaccharide obtained from the same strain (27) .
In addition, the GLP is known to possess the substrate required for the specific activity of the phage 2-associated depolymerase (3) . It has been suggested that the enzyme-substrate interaction may play an important role in the phageadsorptive process (24) . The lysogenization of strain BI with phage 2 produces certain chemical changes in the GLP which result in a loss of depolymerase substrate, and concomitantly, the ability to adsorb phage 2 (11) . The effect of these changes in the GLP are being studied in experimental infections.
The data presented in this report describes the chemical and enzymatic fregmentation of purified GLP in an attempt to assign certain of its biological activities to chemical moieties comprising the GLP molecule.
MATERIALS AND METHODS Microorganism. The organism used for this study, P. aeruginosa strain BI, was originally isolated from a clinical urine specimen and has been previously described (16) .
GLP. The basic procedure used for the extraction and purification of slime GLP has been previously described (5), with modifications (27) . Purity and homogeneity were demonstrated by chromatographic profile, sedimentation pattern as visualized by Schlieren optics, and immunodiffusion as previously described (27) .
GLP fragments. Phenol-treated GLP was obtained by subjecting 30 mg of GLP in 10 ml of water to an equal volume of 90% neutral phenol. The mixture was stirred at 65 to 68 C for 30 min, cooled in ice, and centrifuged at 2,000 x g for 30 min, after which the aqueous layer was removed. After a second extraction of the phenol-phase with an equal volume of water, the aqueous layers were pooled, clarified at 20,000 x g for 1 h, extensively dialyzed against distilled water, and lyophilized (15 (17) , and nitrogen by the micro-Kjeldahl method (29) . A determinatior of N-acetyl groups was also performed (8) .
Qualitative and quantitative sugar analyses were performed with the Technicon auto analyzer. For these determinations, the respective materials were hydrolyzed in 2 N HCl at 100 C for varying time periods. Neutral sugars were determined by the method of Lee et al. (18) , and amino sugars were determined as described by Piez and Morris (22) .
Biological activity. All challenge doses of GLP and fragments were administered by the intraperitoneal route after suspension in 0.1 M sodium phosphate-buffered saline, pH 7.2. Injected mice were observed for 7 days. The mean lethal dose values were determined by method of Reed and Muench (23) . Leukocyte counts were determined by enumeration of the total leukocyte count in a Neubauer hemocytometer (19) , using peripheral blood drawn retro-orbitally. The results are presented as average leukocyte counts per group of five mice. The procedure used for in vitro phagocytosis followed that described by Schwartzman and Boring (26) . A decrease in the number of viable extracellular organisms with time was taken as an indication of phagocytosis (27) . Indirect hemagglutination inhibition tests were performed as previously described (12) with GLP or fragments as inhibitor.
RESULTS
The principal chemical constituents of the purified GLP and various fragments derived from it are presented in Table 1 . As seen in this table, GLP was found to contain, on a weight basis, carbohydrate (34%), protein (14%), and lipid (7%). The remaining weight, as with the other fragments tested, were accounted for by N-acetyl groups, phosphorus, and ash. The total weight accounted for with GLP and with each of the fragments ranged from 72 to 88%. The molecular weight of GLP was estimated to be greater than 100,000. The carbohydrate moiety contained the neutral sugars rhamnose. mannose, galactose, and glucose and the amino sugars glucosamine and galactosamine. Extraction of lipid by the methanol-chloroform procedure indicated that approximately 15% of the lipid was loosely bound or free lipid. The major portion of lipid (85%) was released only after hydrolysis (6 N HCl, 100 C, 2 h), suggesting that it was covalently bound. The water-soluble material obtained after phenol treatment of GLP (phenol-GLP) lacked detectable protein and mannose, but contained carbohydrate (45%) as well as lipid (4.0%). The neutral sugars consisted of rhamnose, galactose, and glucose and the amino sugars were glucosamine and galactosamine. Its molecular weight was estimated to be greater than 100,000.
The water-soluble material obtained after treatment of GLP with acetic acid (acetic acid-GLP) lacked detectable lipid but contained some protein (3%) and consisted largely of carbohydrate (51%) containing rhamnose, mannose, galactose, glucose, glucosamine, and galactosamine. Its molecular weight weight was estimated to be about 60,000.
When GLP was treated with phage 2-depolymerase, low-molecular-weight (less than 10,-000) material was released. This material (depolymerase-GLP) was devoid of detectable lipid but contained protein (22.0%) and carbohydrate (41.4%) comprised ofrhamnose, mannose, galactose, glucose, glucosamine, and galactosamine. The amino sugars present in this material were almost entirely accounted for as free hexosamines. Neutral sugars were also detected in the free state.
The biological activities of various GLP fragments were then compared to those of untreated GLP. The results are presented in Table 2. When injected into mice, the mean lethal dose of untreated GLP was 30 Ag/g of mouse.
The leucopenic effect was observed when leukocyte counts in the peripheral circulation were reduced to 1,800/mm3 as compared to control values of 8,000/mm3. In a phagocytosis system containing mouse leukocytes and bacteria, the number of extracellular organisms was reduced by 92%. However, when GLP was added to the system, an inhibition of phagocytic activity was made evident by an increased number of extracellular bacilli (56%). The antigenic specificity of GLP was shown by its ability to act as inhibi- tor in indirect hemagglutination inhibition tests using GLP-sensitized sheep cells and anti-GLP rabbit serum. The control hemagglutination titer was reduced 32-fold when GLP was used as inhibitor (Table 2) .
When tested by the same procedures, the phenol-GLP fragment possessed all ofthe activities associated with untreated GLP, not differing significantly in regard to mouse lethality, leucopenic response, inhibition of phagocytosis, or antigenic specificity.
In contrast, the acetic acid-GLP fragment was not lethal for mice when tested in concentrations as high as 100 ,uglg of mouse. Further, this fragment failed to produce any evidence of a leucopenia when injected into mice. However, in common with untreated GLP and phenol-GLP, the acetic acid-GLP fragment was active in inhibiting phagocytosis and retained the antigenic specificity of GLP. The lipid-rich precipitate removed after acetic acid treatment was also tested for activity, but negative results were obtained.
The fragments released after GLP treatment with the phage 2-depolymerase (depolymerase-GLP) behaved similar to the acetic acid-GLP fragments in that they were not lethal for mice, nor did they elicit the leucopenic response. However, the depolymerase-GLP fragments differed from the acetic acid-GLP fragments in failing to inhibit phagocytosis and lacking in the antigenic specificity associated with GLP. Thus, the released depolymerase-GLP fragments did not possess any of the biological activities known to be associated with untreated GLP. biological activities of the intact GLP molecule. The studies of Alms and Bass (1, 2), using P. aeruginosa strain PA-7, indicated that the partially purified, alcohol-precipitated fraction from the slime layer consisted mainly of carbohydrate (43%), protein (47%), and lipid (1%). Alms and Bass (1, 2) found that treatment of the alcohol-precipitated fraction with proteolytic enzymes yielded a fraction that was free of detectable protein while retaining the ability to stimulate and react with protective antibody, thus suggesting that the protein moiety does not play a role in the production of protective antibody.
The treatment of the GLP with acetic acid resulted in a fragment composed mainly of carbohydrate and a small amount of protein. This fragment contained no detectable lipid, was devoid of leucopenic and lethal activity, but retained antigenic specificity as well as the ability to inhibit phagocytosis. Since the protein did not appear to be responsible for any of the observed biological activities, it might be presumed that the carbohydrate moiety (with the exception of mannose) must be responsible for the antigenic specificity and the phagocytic inhibition properties of the GLP molecule. Additional testing with individual neutral sugars contained in the acetic acid-GLP fragment failed to further define the determinants of its biological activities. In the studies of Alms and Bass (2), periodic acid treatment destroyed essentially all of the protection-inducing capacity of the slime fraction. Although periodic acid oxidation is not limited to carbohydrates, the results obtained, coupled with the failure of trypsin to destroy immunogenicity, further supports the implication that the carbohydrate fraction is of primary importance in the antigenicity of the slime fraction.
Testing of the lipid-rich precipitate removed after acetic acid treatment failed to account for the absence of leucopenic and lethal properties in the acetic acid-GLP fragment. There may be several reasons to explain the loss of activity. The lipid may have been denatured during the acid hydrolysis; however, we consider this as unlikely. It is also possible that the leucopenia and lethal activity might depend upon some structural relationship between the lipid and the carbohydrate portion of the original molecule, a relationship that is destroyed with the cleavage of the lipid. In either event, this study suggests that the lipid moiety participates, in some manner, in the leucopenic and lethal activity of the GLP molecule.
The fragments released from the GLP after treatment with the depolymerase, although containing both carbohydrate and protein, failed to exhibit any of the biological activities. Since the fragments were devoid of lipid, leucopenic and lethal activities could not be anticipated. The failure to demonstrate antigenic specificity or inhibition of phagocytosis might be explained by the fact that the released fragments represented low-molecular-weight products of the enzymatic treatment.
These studies suggest that the carbohydrate moiety of the GLP molecule is responsible for antigenic specificity and inhibition of phagocytosis, whereas the lipid moiety is probably associated with the leucopenic and lethal effects. No activity can be ascribed to the protein moiety at this time. Finally, it is of interest to speculate on a possible relationship between the extracellular GLP and lipopolysaccharide obtained from the same strain. Chemical, physical, immunological, and biological differences have been reported (27) . The inhibition of phagocytosis by the GLP but not lipopolysaccharide reiter-SENSAKOVIC AND BARTELL ates differences that exist in the carbohydrates of these molecules. Although some differences in the fatty acid composition have been observed (27) , both the GLP and lipopolysaccharide produce similar leucopenic and lethal responses which might be ascribed to a common lipid moiety. It will be of interest to examine this possiblity.
